Aberrant O-glycosylation resulted in Tn antigen expression on the tumor cell surface, which may inhibit apoptosis and provide tumor cell survival advantages through changing death receptor DR4 and/or DR5 activity. This evidence concerns the gene TNFRSF10B and neoplasm.